New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring

... The Change of Upper Limbs PVI in Spinal block (Comparison in High Spinal block and Non-High Spinal Block) At the Tokai ... changed in response to the level of spinal block reached. PVI was recorded in all patients before ...

Semafore Achieves a Preclinical Milestone with SF2626, a PI3K-MEK Dual Pathway Kinase Inhibitor

... that EGFR inhibitors alone are not sufficient to block the downstream activation of the Ras-MAPK pathway. In these patients, it may also be necessary to block both pathways to inhibit cancer cell growth. ... PI3K arena to identify and design inhibitors that block multiple pathways. For more information ...

Parasites That Live Inside Cells Use Loophole to Thwart Immune System

... from St. Jude scientists shows how microbes can block nitric oxide production - a chemical key to the ... that it might be feasible to develop drugs to block such pathogens' biochemical subversion, restoring ... in macrophages grown in the culture dishes can block nitric oxide production in macrophages by ...

Pharmacopeia Announces Third Quarter 2007 Financial Results

... -- PS433540 demonstrated its ability to block the increase in blood pressure induced by ... similar studies with other agents that block the renin-angiotensin system support that this ... successfully demonstrated its ability to block the angiotensin II- induced blood pressure ...

TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel

... binds to certain AK receptors to potentially block the transmission of pain signals, has been ... bind to certain AK receptors to block transmission of pain signals mediated through the ... of glutamate receptors. Because they do not block opioid receptors or constrict blood vessels, the ...

Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease

... advancement of Cognition Therapeutics' pioneering lead molecules that block the activity of the toxic oligomeric form of Abeta protein that interferes ... diseases, and there are currently no therapeutics available to prevent or block the destructive effects of toxic oligomeric proteins. Cognition has ...

Novel Vaccine Approach Offers Hope in Fight Against HIV

... developers. By using gene transfer technology that produces molecules that block infection, the scientists protected monkeys from infection by a virus ... (called immunoadhesins) that were specifically designed to bind to SIV and block it from infecting cells. Once proven to work against SIV in the ...

Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study

... and thrombin is the most potent activator of platelets. Drugs that block platelet activation by other mechanisms, such as the thromboxane- or ... (when added to standard of care), a tendency associated with drugs that block thromboxane or ADP pathways. Specifically, this compound is being ...

The Children's Hospital of Philadelphia: New Gene-Searching Method Uncovers Possible New Targets for Crohn's Disease Drugs

... work by other researchers had shown that monoclonal antibodies that block the IL12 or IL23 receptor show some clinical success in treating Crohn's ... but with side effects to the immune system," said Baldassano. "If we can block other molecules further downstream on a pathway, we may achieve better ...

Hope for Progeria - Successfully Validated on Mice, a Treatment Could Soon be Tested on Children

... protein (whilst it is eliminated in normal cells). In order to inhibit or block the toxicity of progerin, the researchers explored the path of synthesis of this fatty acid. In fact, pharmacological molecules are known to block certain stages in this path of synthesis. After several attempts they ...

Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells

... programs to develop small molecule or monoclonal antibody approaches to block the binding of HIV to CCR5. However, a small molecule or antibody ... of a sufficiently high concentration of these drugs or antibody to block therapeutically relevant numbers of the CCR5 protein, which is present in ...

TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate

... and clinical evidence that supports the further development of drugs that block the glutamate cascade," said Dr. Kurtz. "As the American Headache Society ... By acting at both the AMPA and kainate receptor site to competitively block the binding of glutamate, tezampanel and its oral prodrug, NGX426, have ...

Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial

... is a synthetic peptide that mimics the natural hormone somatostatin to block release of GH. In the recently completed six-month trial, the octreotide ... a long-acting octapeptide that mimics the natural hormone somatostatin to block release of growth hormone (GH), over a six month period. About Indevus ...

SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients

... and thrombin is the most potent activator of platelets. Drugs that block platelet activation by other mechanisms, such as the thromboxane- or ... (when added to standard of care), a tendency associated with drugs that block thromboxane or ADP pathways. Specifically, this compound is being ...

Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia

... NMBA currently available." About the Signal trial(1) This profound block trial was a multicenter, parallel-group study among adult patients ... curarization. About the Spectrum trial(2) In this second profound block trial, 110 patients undergoing elective surgery requiring short duration ...

Promising Data from Paratek Pharmaceuticals' MAR Inhibitor Program Presented in 'Late Breaker' Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy

... in Chicago. The findings demonstrated that small molecule agents which block the activity of ExsA (a MAR protein) in Pseudomonas aeruginosa ... resistance. Paratek is advancing novel compounds that can circumvent or block bacterial resistance involving technology initially developed by Paratek ...

Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients

... Next-Generation Once-Daily CCR5 Antagonist Designed to block HIV Infection of Immune System Cells KENILWORTH, ... is a next-generation extracellular inhibitor of HIV infection designed to block entry of infectious virions into uninfected CD4 cells via antagonism of ...

Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk

... those that could put them in the at-risk population. "We've been aware that certain antidepressants, known as CYP2D6 inhibitor drugs, block the activation of tamoxifen chemically, but this evidence shows that these drugs are putting women in New Jersey and across the nation at a much ...

June 2009 Mayo Clinic Women's HealthSource Highlights Summer Skin Problems, Low Vision and Pilates

... in soft, lightweight, loose-fitting cotton clothing can help prevent heat rash. Avoiding powders and heavy creams can help, too; these products can block skin pores. Treatment -- Sweat reduction and keeping the skin cool help clear up the rash. (Think air conditioning.) Cool-water compresses, ...

Proteolix, Inc. Drug Candidate, PR-957, Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome

... Inc. announced that in an article published today in Nature Medicine, Proteolix's selective immunoproteasome inhibitor PR-957 was shown to block disease progression in mouse models of rheumatoid arthritis in a dose-dependent manner and to completely eliminate visible signs of disease at the ...

Boehringer Ingelheim Unveils Diabetes Pipeline

... sodium-dependent glucose co-transporter-2 inhibitors (SGLT-2 inhibitors), which are a new, emerging class of antidiabetic compounds that block tubular reabsorption of glucose in the kidney.(4) Phase IIb clinical trials for this innovative approach to diabetes treatment are underway. There ...

Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain

... the most widely used drugs in the world for the treatment of arthritis and pain and are a major cause of GI complications, including ulcers. NSAIDs block enzymes and reduce prostaglandins throughout the body and as a consequence, ongoing inflammation, pain, and fever are reduced. Because the ...

New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer

... SSRIs included Celexa(R) (citalopram), Lexapro(R) (escitalopram) and Luvox(R) (fluvoxamine). "We've known that these CYP2D6 inhibitor drugs block the activation of tamoxifen chemically, but this is the first time there's evidence that these drugs are putting women at a much higher risk for ...

New Research Shows Antidepressants May Thwart Breast Cancer Treatment

... the past few years, to give physicians and patients reason to question using certain antidepressants (and other types of medications that might block the CYP2D6 enzyme) together with tamoxifen." Tamoxifen has been used to successfully treat millions of women diagnosed with ...

Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients

... of drug candidates addressing these targets. Semafore is also leveraging its experience in the PI3K arena to identify and design inhibitors that block multiple pathways. For more information visit the Company's web site at www.SemaforePharma.com . ...

Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338

... of many cancer cells, including certain leukemias, lymphomas and other cancers. Preclinical laboratory experiments have shown that MDX-1338 can block the growth of, and even directly kill, selected human tumor cells. The Phase 1, open-label, multicenter, dose-escalation study of MDX-1338 as ...

Clinical Data on Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, to be Presented at the 2009 ASCO Meeting

... of drug candidates addressing these targets. Semafore is also leveraging its experience in the PI3K arena to identify and design inhibitors that block multiple pathways. For more information see the company's web site at www.SemaforePharma.com . ...

Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results

... 40 mg of olmesartan medoxomil will prevent or delay the occurrence of microalbuminuria in comparison to a regimen that excludes agents that directly block the RAS. The secondary objective is to test the hypothesis that treatment with olmesartan medoxomil has a positive effect on cardiovascular and renal ...

National Hemovigilance Pilot Program Launches to Track Adverse Events Associated with Blood Transfusion

... Tissue Safety. "This unique collaborative effort between federal government and the private sector has great potential to be a critical building block for a national biovigilance program, which has as a common goal to improve patient safety and donor health." For more information about the ....

New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel

... narrowed or clogged by cholesterol and fat deposits and cannot supply enough blood to the heart. In some cases, a blood clot may partially or totally block the blood supply to the heart resulting in ACS.(6) Many ACS patients are managed with PCI, which usually includes a stent placement. About ...

Study Confirms: Your Hidden Food Allergies Are Making You Fat

... exposure to incompatible foods, is at the root of metabolic problems like diabetes, cardiovascular disease and obesity. The immune system chemicals block insulin receptors; so, guess what happens to the sugars we eat? - they get stored as fat. Cut the inflammation, cut the fat storage." Along with ...

Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes

... therapy. SERMs are small molecules that bind to and selectively modulate estrogen receptors. These molecules have the ability to stimulate or block estrogen's activity in different types of tissue, functioning as estrogen receptor agonists in some tissues and as estrogen receptor antagonists in ...

Freezing Prostate Cancer Does a Man's Body Good

... below the bladder and in front of the rectum). Prostate cancer affects one in six men, usually older men. As men age, the prostate may get bigger and block the urethra or bladder. This may cause difficulty in urination or can interfere with sexual function. It is estimated that there are more than 2 ...

Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments

... of research in pain management as well as cancer treatment. We look forward to working with our colleagues at Harvard to explore the potential to block pain without affecting motor or other functions, and with the team at Aurigene to discover new oncology drug candidates." About Endo Endo ...

Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist

... have already been granted in the US, Asia and Europe. About PRS-050 PRS-050 Anticalin(R) has been designed to specifically bind and block the signaling activity of vascular endothelial growth factor (VEGF) in cancer. Optimised for extended serum half-life, PRS-050 exhibits comparable ...

Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease

... erectile dysfunction and coronary artery disease may be different manifestations of the same underlying disease process. A buildup of plaque that can block arteries around the heart may plug the smaller penile arteries first, causing erectile dysfunction. Alternatively, arteries may lose elasticity over ...

Nanoemulsion Kills Highly Resistant Bacteria Found in Patients With Cystic Fibrosis

... activity in the presence of cystic fibrosis sputum and against bacterial biofilms, protective coatings that surround bacterial colonies and block the penetration of drugs. "Based on preclinical and clinical safety data from NanoBio's topical anti-infective products, we believe that we ...

Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment

... of a muscle cell in the heart or blood vessels or rate of electrical firing or production of chemical messengers in nerve cells. Calcium antagonists block calcium channels. There are many types of calcium channels. Medicines can be selective to bind just with one type (e.g. heart and blood vessels to ...

Chemoembolization Improving as Liver Cancer Treatment

... it), and then release the drug once in the body, as well as modifications to uniformity and size of the beads themselves so that they can more fully block the blood vessel and further guard against potential leakage of blood that could feed the tumor. More than 21,000 people are diagnosed with ...

Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference

... Results of this study will also help identify the recommended dose for Phase 2 trials. The IAP inhibitors are a novel class of compounds that block the activity of IAP (inhibitor of apoptosis) proteins, thus allowing apoptosis to proceed and causing the cancer cells to die. When IAP proteins are ...